Characteristics And Procedural Complications Of Septal Myectomy For Obstructive Hypertrophic Cardiomyopathy In The United States

Ahmed M. Altibi,Miriam Elman,Yuanzi Zhao,Jad Chehab,Michael Butzner,Stephen Heitner,Daniel Jacoby,Regina Sohn,Ahmad Masri
DOI: https://doi.org/10.1016/j.cardfail.2023.10.149
IF: 6.592
2024-01-01
Journal of Cardiac Failure
Abstract:Background Septal myectomy (SM) outcomes in patients with obstructive hypertrophic cardiomyopathy (oHCM) are derived from experienced centers’ reports or survey data. In this study, we report the characteristics and procedural outcomes of SM in an all-payer oHCM cohort. Methods An observational study using individual-level healthcare claims data (Symphony Health, covers ˃280 million enrollees). Adult patients with oHCM diagnosis who underwent SM (2016-2021) were included. Patients had to have ≥ 1 diagnosis claim (continuous enrollment) in the 120 days prior to SM. Baseline characteristics were derived from claims codes in the 90 days prior to SM. Inpatient complications (within 30 days post-SM) included a composite of: repeat SM, cardiac arrest, CPR, TIA/stroke, anoxic brain damage, hemothorax, tracheotomy, emergency intubation, ECMO, new dialysis, and ventricular septal defect. Results We identified 5,324 patients who underwent SM for oHCM (median age 62.0, 53.5% female, 70% with commercial insurance). Baseline characteristics are shown (Table 1). Concomitant mitral valve repair occurred in 33.4%, mitral valve replacement in 13.2%, papillary muscle intervention in 11.8%, and left atrial appendage clipping/excision in 11.8%. There were 48 (0.9%) patients without claims following SM. Inpatients events occurred in 627 (11.8%) patients. New atrial fibrillation/flutter occurred in 1498 (28.1%) patients and heart block requiring pacemaker implantation occurred in 526 (9.9%) patients. Repeat septal myectomy within 30 days was required in 43 (0.8%) patients. Predictors of inpatients complications are shown in Table 2. Conclusions In a large cohort of patients with oHCM undergoing SM, morbidity resulting from SM complications was substantial. Further representative nationwide studies are needed to understand the long-term non-fatal outcomes of HCM patients post-SM.
cardiac & cardiovascular systems
What problem does this paper attempt to address?